For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Evolus Inc (NASDAQ: EOLS) was $11.31 for the day, down -2.92% from the previous closing price of $11.65. In other words, the price has decreased by $-2.92 from its previous closing price. On the day, 0.77 million shares were traded. EOLS stock price reached its highest trading level at $11.725 during the session, while it also had its lowest trading level at $10.875.
Ratios:
Our analysis of EOLS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.21 and its Current Ratio is at 2.40. In the meantime, Its Debt-to-Equity ratio is 23.55 whereas as Long-Term Debt/Eq ratio is at 23.24.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on April 17, 2025, initiated with a Buy rating and assigned the stock a target price of $21.
On January 29, 2024, Barclays Upgraded its rating to Overweight which previously was Equal Weight and also upped its target price recommendation from $10 to $16.
On June 23, 2022, Needham started tracking the stock assigning a Buy rating and target price of $18.Needham initiated its Buy rating on June 23, 2022, with a $18 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 27 ’25 when MOATAZEDI DAVID sold 6,251 shares for $12.40 per share. The transaction valued at 77,512 led to the insider holds 508,619 shares of the business.
Avelar Rui sold 27,904 shares of EOLS for $369,868 on Mar 18 ’25. The insider now owns 362,467 shares after completing the transaction at $13.26 per share. On Mar 18 ’25, another insider, Beaver Sandra, who serves as the Chief Financial Officer of the company, sold 8,996 shares for $13.26 each. As a result, the insider received 119,243 and left with 173,583 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EOLS now has a Market Capitalization of 719166720 and an Enterprise Value of 762193152. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.70 while its Price-to-Book (P/B) ratio in mrq is 130.06. Its current Enterprise Value per Revenue stands at 2.862 whereas that against EBITDA is -34.743.
Stock Price History:
The Beta on a monthly basis for EOLS is 1.12, which has changed by -0.039082408 over the last 52 weeks, in comparison to a change of 0.097913146 over the same period for the S&P500. Over the past 52 weeks, EOLS has reached a high of $17.82, while it has fallen to a 52-week low of $8.67. The 50-Day Moving Average of the stock is -9.22%, while the 200-Day Moving Average is calculated to be -16.39%.
Shares Statistics:
EOLS traded an average of 847.09K shares per day over the past three months and 915320 shares per day over the past ten days. A total of 63.50M shares are outstanding, with a floating share count of 56.11M. Insiders hold about 11.76% of the company’s shares, while institutions hold 82.34% stake in the company. Shares short for EOLS as of 1744675200 were 7671902 with a Short Ratio of 9.06, compared to 1741910400 on 7051787. Therefore, it implies a Short% of Shares Outstanding of 7671902 and a Short% of Float of 12.32.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The current assessment of Evolus Inc (EOLS) involves the perspectives of 3.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is $-0.09, with high estimates of $-0.03 and low estimates of $-0.13.
Analysts are recommending an EPS of between $-0.04 and $-0.27 for the fiscal current year, implying an average EPS of $-0.12. EPS for the following year is $0.62, with 4.0 analysts recommending between $0.98 and $0.4.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 6 analysts. It ranges from a high estimate of $74M to a low estimate of $70.68M. As of the current estimate, Evolus Inc’s year-ago sales were $59.33MFor the next quarter, 6 analysts are estimating revenue of $82.33M. There is a high estimate of $85.48M for the next quarter, whereas the lowest estimate is $80.6M.
A total of 7 analysts have provided revenue estimates for EOLS’s current fiscal year. The highest revenue estimate was $355M, while the lowest revenue estimate was $345.49M, resulting in an average revenue estimate of $351.13M. In the same quarter a year ago, actual revenue was $266.27MBased on 7 analysts’ estimates, the company’s revenue will be $466.72M in the next fiscal year. The high estimate is $482M and the low estimate is $444.9M.
